TANGO THERAPEUTICS INC (TNGX:NASDAQ)
$21.94 -0.41 (-1.8345%)
Analysed TANGO THERAPEUTICS INC (TNGX:NASDAQ) News Sources
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
11-08-2026
yahoo.com
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
12-08-2026
yahoo.com
RVMD Secures FDA Win, Gets Nod for Rasonque in Pancreatic Cancer
27-08-2026
yahoo.com
Is Tango Therapeutics (TNGX) Price Justified After Its 7x Surge In One Year
10-06-2026
yahoo.com
Tango Therapeutics Appoints Robert Azelby to Board of Directors
22-06-2026
yahoo.com
Tango Therapeutics Rides a New Precision Oncology Trend in 2026
02-07-2026
yahoo.com
Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues
15-07-2026
yahoo.com
How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48%
22-07-2026
yahoo.com
Tango Therapeutics Announces Executive Chair Transition
06-08-2026
yahoo.com
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
01-09-2026
yahoo.com
What is the current price of TANGO THERAPEUTICS INC (TNGX:NASDAQ)?
The current price of TANGO THERAPEUTICS INC (TNGX:NASDAQ) is $21.94.
TANGO THERAPEUTICS INC (TNGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TANGO THERAPEUTICS INC (TNGX:NASDAQ) since the previous trading day is $-0.41.
TANGO THERAPEUTICS INC (TNGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TANGO THERAPEUTICS INC (TNGX:NASDAQ) since the previous trading day is -1.8345%.
What is the most recent average sentiment score for TANGO THERAPEUTICS INC (TNGX:NASDAQ)?
The most recent average sentiment score for TANGO THERAPEUTICS INC (TNGX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for TANGO THERAPEUTICS INC (TNGX:NASDAQ)?
The most recent sentiment for TANGO THERAPEUTICS INC (TNGX:NASDAQ) is .
SEC-8K** Filing Available For TANGO THERAPEUTICS INC (TNGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.